Effectiveness of psychopharmacology in Anorexia Nervosa treatment
By:
References
- 1. Bissada H. et al.: Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry, 165, 10,2008.
- 2. Court A. et al.: Investigating the effectiveness, safety and tolerability of quetiapine in the treatment of anorexia nervosa in young people: a pilot study. J Psychiatr Res., 44, 15, 2010.
- 3. Hagman J. et al.: A double-blind, placebo-controlled study of risperidone for the treatment of adolescents and young adults with anorexia nervosa: a pilot study. J Am Acad Child Adolesc Psychiatry, 50, 9, 2011.
- 4. Kaye W.H. et al.: Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa. Biol Psychiatry, 2001 49, 7, 2001.
- 5. Kouidrat Y. et al.: Eating disorders in schizophrenia: implications for research and management. Schizophr Res Treatment, 2014.
- 6. Kracke E.J., Tosh A.K.: Treatment of anorexia nervosa with longterm risperidone in an outpatient setting: case study. Springerplus, 2, 3, 2014.
- 7. Kucharska-Pietura K. et al.: The recognition of emotion in the faces and voice of anorexia nervosa. Int J Eat Disord., 35, 1, 2004.
- 8. Lacey J.H., Crisp A.H.: Hunger, food intake and weight: the impact of clomipramine on a refeeding anorexia nervosa population. Postgrad Med J., 56, 1, 1980.
- 9. Madden S. et al.: Burden of eating disorders in 5-13-year-old children in Australia. Med J Aust., 20, 8, 2009.
- 10. Okita K. et al.: Tandospirone, a 5-HT1A partial agonist is effective in treating anorexia nervosa: a case series. Annals of General Psychiatry, 12, 7, 2013.
- 11. Pinhas L. et al.: Incidence and age-specific presentation of restrictive eating disorders in children: a Canadian Paediatric Surveillance Program study. Arch Pediatr Adolesc Med., 165, 10, 2011.
- 12. Powers P.S., Klabunde M., Kaye W.: Double-blind placebo-controlled trial of quetiapine in anorexia nervosa. Eur Eat Disord Rev., 20, 4, 2012.
- 13. Smink F.R., van Hoeken D., Hoek H.W.: Epidemiology of eating disorders: incidence, prevalence and mortality rates. Curr Psychiatry Rep., 14, 4, 2012.
- 14. Strobel M. et al.: Paroxetine versus clomipramine in female adolescents suffering from anorexia nervosa and depressive episode - a retrospective study on tolerability, reasons for discontinuing the antidepressive treatment and different outcome measurements. Z Kinder Jugendpsychiatr Psychother., 32, 4, 2004.
- 15. Umehara H., Iga J., Ohmori T.: Successful Treatment of Anorexia Nervosa in a 10-year-old Boy with Risperidone Long-acting Injection. Clin Psychopharmacol Neurosci., 12, 1, 2014.
- 16. Walsh B.T. et al.: Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial. JAMA, 14, 22, 2006
Language: English
Page range: 69 - 71
Submitted on: Mar 3, 2015
Accepted on: Apr 7, 2015
Published on: Jul 16, 2015
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2015 Lukasz Zadka, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.